UA74347C2 - Безводна або майже безводна, стабільна рідка композиція - Google Patents

Безводна або майже безводна, стабільна рідка композиція

Info

Publication number
UA74347C2
UA74347C2 UA2002043345A UA200243345A UA74347C2 UA 74347 C2 UA74347 C2 UA 74347C2 UA 2002043345 A UA2002043345 A UA 2002043345A UA 200243345 A UA200243345 A UA 200243345A UA 74347 C2 UA74347 C2 UA 74347C2
Authority
UA
Ukraine
Prior art keywords
water
free
stable liquid
sodium
liquid formulation
Prior art date
Application number
UA2002043345A
Other languages
English (en)
Russian (ru)
Inventor
Мікаель Брюллс
Original Assignee
Астразенека Аб
Астра АБ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб, Астра АБ filed Critical Астразенека Аб
Publication of UA74347C2 publication Critical patent/UA74347C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Винахід стосується стабільних рідких композицій безводного або майже безводного поліетиленгліколевого розчину натрієвої або калієвої солі інгібітору Н+, К+ - АТФази формули 1 або натрієвої або калієвої солі її одиничного енантіомера. Альтернативно, натрієву або калієву сіль інгібітору Н+, К+ - АТФази можна створювати in situ у поліетиленгліколевому розчині додаванням гідроксиду натрію або калію разом з активною сполукою. Винахід стосується також отримання заявленої композиції, використання стабільних рідких композицій у медицині та у лікуванні шлунково-кишкових захворювань.
UA2002043345A 1999-10-22 2000-10-13 Безводна або майже безводна, стабільна рідка композиція UA74347C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903831A SE9903831D0 (sv) 1999-10-22 1999-10-22 Formulation of substituted benzimidazoles
PCT/SE2000/001992 WO2001028558A1 (en) 1999-10-22 2000-10-13 Formulation of substituted benzimidazoles

Publications (1)

Publication Number Publication Date
UA74347C2 true UA74347C2 (uk) 2005-12-15

Family

ID=20417464

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002043345A UA74347C2 (uk) 1999-10-22 2000-10-13 Безводна або майже безводна, стабільна рідка композиція

Country Status (36)

Country Link
US (1) US6730685B1 (uk)
EP (1) EP1274427B1 (uk)
JP (1) JP2003512327A (uk)
KR (1) KR100785603B1 (uk)
CN (1) CN1213751C (uk)
AR (1) AR029005A1 (uk)
AT (1) ATE304851T1 (uk)
AU (1) AU782866B2 (uk)
BG (1) BG65580B1 (uk)
BR (1) BR0014895A (uk)
CA (1) CA2425199C (uk)
CO (1) CO5261533A1 (uk)
CY (1) CY1106055T1 (uk)
CZ (1) CZ20021375A3 (uk)
DE (1) DE60022789T2 (uk)
DK (1) DK1274427T3 (uk)
EE (1) EE05175B1 (uk)
ES (1) ES2246903T3 (uk)
HK (1) HK1051142A1 (uk)
HU (1) HUP0203121A3 (uk)
IL (2) IL149107A0 (uk)
IS (1) IS2196B (uk)
MX (1) MXPA02003900A (uk)
MY (1) MY131971A (uk)
NO (1) NO329545B1 (uk)
NZ (1) NZ518155A (uk)
PL (1) PL199868B1 (uk)
RU (1) RU2286782C2 (uk)
SE (1) SE9903831D0 (uk)
SI (1) SI1274427T1 (uk)
SK (1) SK286266B6 (uk)
TR (1) TR200201103T2 (uk)
TW (1) TWI236372B (uk)
UA (1) UA74347C2 (uk)
WO (1) WO2001028558A1 (uk)
ZA (1) ZA200202905B (uk)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2775616C (en) * 2000-08-04 2013-09-17 Takeda Pharmaceutical Company Limited Salts of benzimidazole compound and application thereof
AU2001278755A1 (en) * 2000-08-18 2002-03-04 Takeda Chemical Industries Ltd. Injections
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2848555B1 (fr) 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
KR20130066701A (ko) * 2003-02-24 2013-06-20 미쓰비시 타나베 파마 코퍼레이션 테나토프라졸의 거울상 이성질체 및 치료를 위한 그 용도
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060089376A1 (en) * 2004-10-27 2006-04-27 Joshi Ramesh A Tenatoprazole salts and process of preparation thereof
BRPI0711048A2 (pt) * 2006-05-09 2011-08-23 Astrazeneca Ab formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável
CN100411613C (zh) * 2006-12-08 2008-08-20 中国药科大学 一种奥美拉唑速释固体制剂及其制备方法
EP3218510B1 (en) 2014-11-13 2019-01-02 3M Innovative Properties Company Kit comprising atp-diphosphohydrolase for detecting bacterial atp in a sample
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
DK399389A (da) 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
KR930000861B1 (ko) 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물
ATE144421T1 (de) 1992-07-28 1996-11-15 Astra Ab Injizierbares arzneimittel und satz, die omoprazol oder verwandte verbindungenenthalten
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
TW359614B (en) 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
MXPA02003900A (es) 2002-09-30
BG106602A (en) 2002-12-29
IS6347A (is) 2002-04-17
EP1274427A1 (en) 2003-01-15
CY1106055T1 (el) 2011-04-06
HK1051142A1 (en) 2003-07-25
EP1274427B1 (en) 2005-09-21
ZA200202905B (en) 2003-07-14
CA2425199A1 (en) 2001-04-26
SK286266B6 (sk) 2008-06-06
TWI236372B (en) 2005-07-21
NZ518155A (en) 2004-07-30
ES2246903T3 (es) 2006-03-01
PL199868B1 (pl) 2008-11-28
EE05175B1 (et) 2009-06-15
HUP0203121A2 (hu) 2003-01-28
IL149107A (en) 2008-04-13
CN1382048A (zh) 2002-11-27
JP2003512327A (ja) 2003-04-02
AR029005A1 (es) 2003-06-04
NO20021860D0 (no) 2002-04-19
CA2425199C (en) 2010-12-07
SK5392002A3 (en) 2002-10-08
CZ20021375A3 (cs) 2002-09-11
NO329545B1 (no) 2010-11-08
BR0014895A (pt) 2002-06-18
EE200200204A (et) 2003-04-15
ATE304851T1 (de) 2005-10-15
DE60022789D1 (de) 2006-02-02
DE60022789T2 (de) 2006-06-22
DK1274427T3 (da) 2005-12-27
WO2001028558A1 (en) 2001-04-26
IS2196B (is) 2007-01-15
BG65580B1 (bg) 2009-01-30
SE9903831D0 (sv) 1999-10-22
KR100785603B1 (ko) 2007-12-14
MY131971A (en) 2007-09-28
HUP0203121A3 (en) 2004-01-28
TR200201103T2 (tr) 2002-08-21
PL354926A1 (en) 2004-03-22
IL149107A0 (en) 2002-11-10
NO20021860L (no) 2002-05-21
KR20020059637A (ko) 2002-07-13
US6730685B1 (en) 2004-05-04
CO5261533A1 (es) 2003-03-31
AU782866B2 (en) 2005-09-01
CN1213751C (zh) 2005-08-10
RU2286782C2 (ru) 2006-11-10
AU1182301A (en) 2001-04-30
SI1274427T1 (sl) 2006-02-28

Similar Documents

Publication Publication Date Title
UA74347C2 (uk) Безводна або майже безводна, стабільна рідка композиція
UY27320A1 (es) Nuevas composiciones farmacéuticas
RU2412688C2 (ru) Стабилизированная кислород-выделяющая композиция
TNSN03110A1 (en) Azaindoles.
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
TR200103474T2 (tr) Bileşimlerin anti-bakteriyel madde olarak yeni kullanımları
MXPA04004601A (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
BR0113751A (pt) Composições cosméticas e farmacêuticas e seus empregos
TR200103153T2 (tr) Yeni bileşimler
HUP0103431A2 (hu) 5-HT4 receptor agonista vagy antagonista hatóanyagot tartalmazó, orális gyógyászati készítmény
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
GR3015637T3 (en) Stable sodium hypochlorite solution.
ATE92303T1 (de) Periodontische zusammensetzung und verfahren.
ES2179526T3 (es) Analogos y profarmacos del paclitaxel solubles en agua.
GEP20043231B (en) Resorcinol Composition
YU13599A (sh) Primena farmaceutske kompozicije za dobijanje leka u obliku gela
GB2356347B (en) Pharmaceutical compositions and their use
DE69815724D1 (de) Transparente körperpflegemittel
IT1306147B1 (it) Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
UA88446C2 (uk) Препарат, що містить аскорбінову кислоту, для лікування та профілактики вагінальних грибкових інфекцій
NZ505080A (en) Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid
PL350413A1 (en) Pharmaceutical effervescent formulation containing metamizol
NO983217D0 (no) Terapeutiske anti-astmamidler som inneholder selenforbindeler